Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$3.41 – $4.93
95% from low
No one on the platform currently holds GNFT.
No tracked institution reports a position in GNFT as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-03-10 | $8.9293 |
No one on the platform has traded GNFT yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$GNFT bear: 6.78€ base: 10.26€ bull: 15€ Intrinsic value: 3.93€ Sell price target: 10.51€ (12% margin) Reward / risk: 0.39 Risk / reward: 2.54
View on StockTwits ↗$GNFT what's everyones thought on this. How far up can it go?!
View on StockTwits ↗Top Stocks Hitting 52-Week High $AXTI $IPG $GNFT $TSM $FRO
View on StockTwits ↗$GNFT Risk appetite is present but conditioned on validation. Governance alignment should reduce uncertainty over time. Risk compresses once delivery patterns become predictable. Execution quality will determine whether momentum is sustainable.
View on StockTwits ↗$GNFT Upside exists, but only alongside disciplined prioritization and resource control. Cash generation will determine how self-sustaining growth becomes. If milestones track on schedule, sentiment can re-rate faster than fundamentals. Future returns will be dictated by execution quality, not headlines.
View on StockTwits ↗$GNFT GNS561 in CCA – Data readout from the ongoing Phase 1b clinical trial are expected by the end of 2025.
View on StockTwits ↗$GNFT announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market https://ir.genfit.com/news-releases/news-release-details/genfit-announces-effectiveness-voluntary-delisting-american
View on StockTwits ↗$GPCR $NVO $NVO’s next M&A wave likely targets small-cap metabolic names it can absorb fast 👀 🧩 $GPCR — oral GLP-1, sweet spot ~$2-4B 💊 $IVA — late-stage MASH, ~$1B w/ CVR 🧬 $GNFT — liver bolt-on <$0.5B 🐍 $ZEAL — combo peptide giant $7-14B (too rich?) Smart money’s betting Novo reloads with bite-sized deals, not another bidding war.
View on StockTwits ↗$GNFT 🚀🚀 $PHAR 🚀🚀$NYXH 🚀🚀 Winners for today… big winners for the future 🥂🚀🥂🚀🥂
View on StockTwits ↗$GNFT https://ir.genfit.com/news-releases/news-release-details/genfit-enters-research-collaboration-everzom-advance-exosome
View on StockTwits ↗$GNFT https://ir.genfit.com/news-releases/news-release-details/genfit-presents-promising-new-preclinical-data-ntzg1090n
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.